Job Description

　　It is an exciting moment for our company as we build an industry leading cardiometabolic business that aspires to impact these devastating diseases on a global scale. Our company has made significant progress with advancing our cardiometabolic and rare disease pipeline this year. Moreover, we expect 8 approvals in the next five years across our broad and exciting portfolio.

　　With these advancements, the Cardiometabolic & Respiratory team will also transform as we ensure the business is fully resourced to support the next phase of growth. With a goal of building an industry leading team, we must continuously attract and inspire talent; build patient centric commercial capabilities and drive best in class launches to enable long term value realization.

　　The AVP, Global Metabolism and Thrombosis will lead two key pipeline products in our company's expanding cardiometabolic portfolio, specifically in chronic kidney disease/ end stage renal disease and in Non-Alcoholic Steatohepatitis (NASH)/Obesity. Both products have the potential to best in class products and blockbuster revenue.

　　The Glucagon Like Peptide-1 (GLP-1) market is expected to be the largest growth opportunity in the pharmaceutical industry, driven by the global obesity epidemic. The product is being developed with a focus on NASH and has been shown to have profound weight loss benefits as well. The product has the potential to deliver best in class NASH efficacy as compared to other GLP-1 based therapies and in the broad metabolic/obesity market. The product is expected to enter Phase III in across the full range of NASH patients. This role will also lead the block-buster Diabetes portfolio and drive profitability and late lifecycle plans.

　　The Thrombosis market is a large and exciting market opportunity. The aspiration for the product is to be the foundation therapy in the prevention of major thrombotic cardiovascular events and risk of bleeding events in Chronic Kidney Disease (CKD)/ End-stage kidney disease (ESKD) patients. Patients with late-stage Cyclin Dependent Kinase (CKD) or are at significantly higher risk of major thrombotic cardiovascular events with no approved anticoagulant therapies to reduce risk for Cardiovascular CV events. The product is expected to enter Phase III in 2024.

　　The Global Brand Leader will play an important role in supporting the commercial transformation and leadership of our launches, pipeline including new ways of working, embedding advanced analytics, evolving the commercial models and building value for patients, payers and Health Care Provider (HCP). This role will also support the commercial leadership in our Business Development efforts to help support growth and leadership in this space.

　　Specific Responsibilities Include:

　　Oversee realization of the vision and enterprise strategy for our Diabetes portfolio.

　　Commercial leadership and partnership with our Research and Development (R&D) Division to optimize product development team (PDT) and global brand strategy, development plans, and launch readiness.

　　Lead the Global Commercial team and ensure integration of marketing, policy, GMAx, Medical, Clinical and CORE in the development of an integrated brand strategy. Collaborate with the key markets, other key stakeholders to ensure a unified strategy; global brand strategy, value evidence, rapid and broad access, launch readiness, customer centric commercial model.

　　Support development efforts with R&D and Corporate Business Development

　　Collaborate with Business Development Team (Global and Regional) to identify inorganic growth opportunities in the CV/ Metabolic space.

　　Work closely with Early Development Commercial Leads to ensure commercial insights within the diabetes/ metabolic space are leveraged in the development of pre-phase III assets

　　Drive forward digital innovation, focused on strategy development, optimization of analytics as well as tactic development work through the GCT and Key markets to support consistent execution at local country level

　　Engage policy team to identify relevant policy levers to support portfolio access

　　Maintain strong level of collaboration with our Manufacturing colleagues to inform short-term and long-term supply chain decisions.

　　Partner with R&D CORE team to ensure real world evidence plan is fully aligned with portfolio priorities

　　Partner with Cardiometabolic Global Marketing Colleagues to invest in each other’s development, build a culture of inclusivity and stretch our collective team’s thinking by challenging the status quo for the purpose of creating stronger outcomes

　　Education Minimum Requirement: Bachelor's Degree

　　Preferred Education: Advanced Degree (MBA)

　　Required Experience and Skills:

　　Minimum of 10 years combined marketing, sales, market access, or related experiences in pharmaceutical or biotechnology industries including Cardiovascular and payer experience.

　　Launch and pipeline strategy experience is preferred

　　Preferred Experience and Skills:

　　Leadership and Impact: Proven track record of high-performance launches and driving business results.

　　Innovative Thinking: Demonstrated ability to leverage innovation to drive results

　　Collaboration: Strong collaboration skills, both within commercial teams and cross divisional teams including R&D and manufacturing, medical affairs, CORE/RWE.

　　Communication: Ability to clearly articulate messages/information across the enterprise and to all levels, including highest levels of senior leadership

　　Understanding of Drug Development Process (Early and Late Stage)

　　Strategic Thinking: Proven ability to manage complex data, insights and create clear patient and customer centric strategies

　　Challenging Status Quo: Ability to push past internal obstacles to drive initiatives forward

　　NOTICE FOR INTERNAL APPLICANTS

　　In accordance with Managers' Policy - Job Posting and Employee Placement, all employees subject to this policy are required to have a minimum of twelve (12) months of service in current position prior to applying for open positions.

　　If you have been offered a separation benefits package, but have not yet reached your separation date and are offered a position within the salary and geographical parameters as set forth in the Summary Plan Description (SPD) of your separation package, then you are no longer eligible for your separation benefits package. To discuss in more detail, please contact your HRBP or Talent Acquisition Advisor.

　　Employees working in roles that the Company determines require routine collaboration with external stakeholders, such as customer-facing commercial, or research-based roles, will be expected to comply not only with Company policy but also with policies established by such external stakeholders (for example, a requirement to be vaccinated against COVID-19 in order to access a facility or meet with stakeholders). Please understand that, as permitted by applicable law, if you have not been vaccinated against COVID-19 and an essential function of your job is to call on external stakeholders who require vaccination to enter their premises or engage in face-to-face meetings, then your employment may pose an undue burden to business operations, in which case you may not be offered employment, or your employment could be terminated. Please also note that, where permitted by applicable law, the Company reserves the right to require COVID-19 vaccinations for positions, such as in Global Employee Health, where the Company determines in its discretion that the nature of the role presents an increased risk of disease transmission.

　　Current Employees apply HERE (https://wd5.myworkday.com/msd/d/inst/1422$1533/rel-task/3001$14.htmld)

　　Current Contingent Workers apply HERE (https://wd5.myworkday.com/msd/d/task/1422$4020.htmld)

　　US and Puerto Rico Residents Only:

　　Our company is committed to inclusion, ensuring that candidates can engage in a hiring process that exhibits their true capabilities. Please click here (https://survey.sogosurvey.com/r/aCdfqL) if you need an accommodation during the application or hiring process.

　　We are an Equal Opportunity Employer, committed to fostering an inclusive and diverse workplace. All qualified applicants will receive consideration for employment without regard to race, color, age, religion, sex, sexual orientation, gender identity, national origin, protected veteran status, or disability status, or other applicable legally protected characteristics. For more information about personal rights under the U.S. Equal Opportunity Employment laws, visit:

　　EEOC Know Your Rights (https://www.eeoc.gov/sites/default/files/2022-10/22-088_EEOC_KnowYourRights_10_20.pdf)

　　EEOC GINA Supplement​

　　Pay Transparency Nondiscrimination (https://www.dol.gov/sites/dolgov/files/OFCCP/pdf/pay-transp_%20English_formattedESQA508c.pdf)

　　We are proud to be a company that embraces the value of bringing diverse, talented, and committed people together. The fastest way to breakthrough innovation is when diverse ideas come together in an inclusive environment. We encourage our colleagues to respectfully challenge one another’s thinking and approach problems collectively.

　　Learn more about your rights, including under California, Colorado and other US State Acts (https://www.msdprivacy.com/us/en/CCPA-notice/)

　　U.S. Hybrid Work Model

　　Effective September 5, 2023, employees in office-based positions in the U.S. will be working a Hybrid work consisting of three total days on-site per week, generally Tuesday, Wednesday and either Monday or Thursday, although the specific days may vary by site or organization, with Friday designated as a remote-working day, unless business critical tasks require an on-site presence. This Hybrid work model does not apply to, and daily in-person attendance is required for, field-based positions; facility-based, manufacturing-based, or research-based positions where the work to be performed is located at a Company site; positions covered by a collective-bargaining agreement (unless the agreement provides for hybrid work); or any other position for which the Company has determined the job requirements cannot be reasonably met working remotely. Please note, this Hybrid work model guidance also does not apply to roles that have been designated as “remote”.

　　Under New York State, Colorado State, Washington State, and California State law, the Company is required to provide a reasonable estimate of the salary range for this job. Final determinations with respect to salary will take into account a number of factors, which may include, but not be limited to the primary work location and the chosen candidate’s relevant skills, experience, and education.

　　Expected salary range:

　　$268,500.00 - $422,700.00

　　Available benefits include bonus eligibility, health care and other insurance benefits (for employee and family), retirement benefits, paid holidays, vacation, and sick days. For Washington State Jobs, a summary of benefits is listed here (https://www.benefitsatmerck.com/) .

　　Search Firm Representatives Please Read Carefully

　　Merck & Co., Inc., Rahway, NJ, USA, also known as Merck Sharp & Dohme LLC, Rahway, NJ, USA, does not accept unsolicited assistance from search firms for employment opportunities. All CVs / resumes submitted by search firms to any employee at our company without a valid written search agreement in place for this position will be deemed the sole property of our company. No fee will be paid in the event a candidate is hired by our company as a result of an agency referral where no pre-existing agreement is in place. Where agency agreements are in place, introductions are position specific. Please, no phone calls or emails.

　　Employee Status:

　　Regular

　　Relocation:

　　VISA Sponsorship:

　　Travel Requirements:

　　Flexible Work Arrangements:

　　Shift:

　　Valid Driving License:

　　Hazardous Material(s):

　　Requisition ID: R277915